|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
50678997
???header.onlineuser??? :
385
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"hyun jee"???jsp.browse.items-by-author.description???
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2024-10-10 |
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2-Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2-Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
|
Yao;Herui;Yan;Min;Tong;Zhongsheng;Wu;Xinhong;Ryu;Min-Hee;Park;John, John J.;Kim;Hyun, Jee;Zhong;Yahua;Zhao;Yiming;Voskoboynik;Mark;Yin;Yongmei;Liu;Kan;Kaubisch;Andreas;Liu;Caigang;Zhang;Jian;Wang;Shouman;Im;Seock-Ah;Ganju;Vinod;Barve;Minal;Li;Hui;Ye;Changsheng;Roy;Amitesh, C.;Bai;Li-Yuan;Yen;Chia-Jui;Gu;Shanzhi;Lin;Yung-Chang;Wu;Lingying;Bao;Lequn;Zhao;Kaijing;Shen;Yu;Rong;Shangyi;Zhu;Xiaoyu;Song;Erwei |
| 國立成功大學 |
2024-09 |
Trastuzumab deruxtecan versus trastuzumab emtansine in Asian patients with HER2-positive metastatic breast cancer
|
Iwata;Hiroji;Xu;Binghe;Kim;Sung-Bae;Chung;Wei-Pang;Park;Hee, Yeon;Kim;Hwan, Min;Tseng;Ling-Ming;Chung;Chi-Feng;Huang;Chiun-Sheng;Kim;Hyun, Jee;Chiu;Yan, Joanne Wing;Yamashita;Toshinari;Li;Wei;Egorov;Anton;Nishijima;Soichiro;Nakatani;Shunsuke;Nishiyama;Yuji;Sugihara;Masahiro;Cortes;Javier;Im;Seock-Ah |
| 國立成功大學 |
2024-01-20 |
Coformulated quavonlimab and pembrolizumab (pembro) in combination with lenvatinib (lenva) as first-line (1L) therapy for patients (pts) with advanced hepatocellular carcinoma (HCC): Phase 2 KEYSTEP-004 study.
|
Rimassa;Lorenza;Li;Daneng;Ikeda;Masafumi;Yarchoan;Mark;Ryoo;Baek-Yeol;Kossler;Thibaud;Lim;Ho-Yeong;Kwiatkowski;Mariusz;Chang;Ting-Tsung;Kim;Hyun, Jee;Casadei-Gardini;Andrea;Kudo;Masatoshi;Ren;Zhenggang;Calvo;Varela, Maria;Llovet;Josep, M.;Zhang;Yayan;Hatogai;Ken;Siegel;Abby, B.;Cheng;Ann-Lii |
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
